Assessment of Needs
This webinar is designed for clinicians caring for people with HIV, including residents, infectious diseases fellows, advanced practitioners, and practitioners in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs who are new to the field of HIV patient care. It is also relevant for clinicians who are interested in a review of the field. In the webinar, experts in the field will describe the core principles of HIV management, including pathogenesis of HIV infection, mechanism of action of antiretroviral drugs, initiating antiretroviral therapy, and primary care for people with HIV.
On completion of this webinar, learners will be able to describe:
- Events of early HIV infection
- Laboratory markers following HIV acquisition
- Basic mechanisms of antiretroviral therapy
- Antiretroviral regimens based on patient parameters
- Appropriate vaccinations for adults with HIV, focusing on hepatitis B, pneumococcus, and SARS CoV-2
- Appropriate cancer screening for people with HIV, focusing on cervical and anal cancer
- Screening for cardiovascular disease and managing hyperlipidemia in persons with HIV
- Screening for polypharmacy and frailty in persons with HIV
Who Should Attend
This webinar is designed for clinical decision makers who are in training, new to, or are interested in a review of HIV patient care, including physicians, physician assistants, nursing professionals, pharmacists, and other health care professionals.
Though attendance for the 2021 Ryan White HIV/AIDS CLINICAL CONFERENCE is limited to HIV physicians, nurse practitioners, physician assistants, and primary clinical decision makers in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs, registration for this webinar is open to all.
Individual registration is required in order to receive CME credit or a certificate of participation.
Registration closes on Tuesday, September 28, 2021, 10:00 AM (PT).
Certificates will be available after the completion of the evaluation and claim form.
For more information or questions, please contact the registration department at firstname.lastname@example.org or 415-544-9400.
Conflicts of Interest
In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg, faculty, Scientific Leadership Board, Governance Board, and program planner) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities.
The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”
IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenter and planners/reviewers is below and in the slides prior to the presentation of educational content.
Dr Gandhi has no relevant financial affiliations to disclose. (Updated 09/28/21)
Dr Saag has received research grants and support awarded to his institution from Gilead Sciences, Inc., and ViiV Healthcare. (Updated 9/28/2021)
Dr Thompson has received grants for research paid to her institution (ARCA, Atlanta, GA) by Bristol Myers Squibb, Cepheid Inc., Cytodyn Inc, Frontier Biotechnologies, Gilead Sciences, Inc., GlaxoSmithKline, Merck Sharp Dohme, and ViiV Healthcare. (Updated 09/28/21)
Planner/Reviewer 1 has no relevant financial relationships with ineligible companies to disclose. (Updated 09/28/21)
Planner/Reviewer 2 has no relevant financial relationships with ineligible companies to disclose. (Updated 09/28/21)
All relevant financial relationships have been mitigated.
Continuing Education Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. IAS-USA, the CME activity provider, will submit your participant information (eg, name, date of birth, activity credits earned, ABIM MOC number) to ABIM through the PARS system for the purpose of reporting ABIM MOC credits.
Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 2 hours of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.
This program is approved for 2 hours of pharmacotherapy credit.
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 2 contact hours (0.2 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
UAN # 0761-9999-21-304-L02-P
This webinar is part of the virtual 2021 Ryan White HIV/AIDS Program CLINICAL CONFERENCE. The virtual RWHAP CLINICAL CONFERENCE is planned with and supported by the HIV/AIDS Bureau, Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) and is sponsored and organized by the International Antiviral Society-USA (IAS-USA). This conference is coordinated through the RWHAP AIDS Education and Training Centers (AETC) clinician training network.
This conference is funded by Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number U1OHA28686 (AIDS Education and Training Center National Coordinating Resource Center) awarded François-Xavier Bagnoud Center from the Rutgers University School of Nursing with a sub award to IAS–USA to sponsor this CME activity.